SIRT1 and cholestasis: The detrimental impact of SIRT1 overexpression during cholestasis was further confirmed in an additional experimental model where 0.1% DDC–fed SIRToe mice showed increased alkaline phosphatase (AP) serum levels (Supporting Fig. S6A) and wider areas of liver necrosis after 1 week of treatment (Supporting Fig. S6B).